Treatment of Human Tumor Xenografts with Monoclonal Antibody 806 in Combination with a Prototypical Epidermal Growth Factor Receptor–Specific Antibody Generates Enhanced Antitumor Activity
Rushika M. Perera(University of California, San Francisco), Terrance G. Johns(La Trobe University)
Cited by 103
Related Papers
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k
Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
|Nature|2015|788
The epidermal growth factor receptor variant <scp>III</scp> (<scp>EGFR</scp>v<scp>III</scp>): where wild things are altered
|FEBS Journal|2013|357